ABVC · ABVC BioPharma Inc
United States · RS rating 40 · As of 2026-11-03
| Price | 0.99 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 40 / 59 / 61 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 28 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +50.0% |
| Sales growth Q/Q | +100.0% |
| Distance from 52-week high | +67.0% |
| Market cap (USD) | $29.2M |